Insurance coverage

In-network with most major health plans

Insurance coverage

In-network with most major health plans

Integrated Oncology will file claims for insured patients directly to Medicare, Medicaid, many insurance companies, and managed care plans. Integrated Oncology is contracted with approximately 800 payers across the country, including Aetna, CIGNA, UnitedHealthcare, Humana, and the majority of Blue Cross and Blue Shield plans.  It is always important to verify and update insurance information and know which testing laboratories are in-network or participating providers for your benefit plan. This information may impact your level of coverage. 

When contracting with insurance companies and managed care plans, Integrated Oncology contracts under the names of Esoterix Genetic Laboratories, LLC (EGL) with Tax ID Number: 27-3267315 and/or Accupath Diagnostic Laboratories (Accupath) with Tax ID Number 33-0731972.   Both EGL and Accupath are both wholly-owned subsidiaries of Laboratory Corporation of America® Holdings.

Please note: The following lists contain Integrated Oncology’s most commonly billed insurance carriers, which are subject to change, and not all-inclusive. Certain exceptions may apply by geographic or specific member coverage or plan. 

For oncology-related testing being performed at Integrated Oncology’s facilities in Brentwood, TN and Phoenix, AZ, please refer to the Accupath National Listing.

For oncology-related testing being performed at Integrated Oncology’s facilities in New York City, NY and Shelton, CT, please refer to the EGL National and State Listings (below).

This list contains EGL’s most commonly billed insurance carriers, which is subject to change, and is not all-inclusive. Certain exceptions may apply by geographic or specific member coverage or plan. If you have any questions regarding a specific insurance carrier, please contact your local Integrated Oncology Representative or call 1.800.845-6167.

* Group/Employer/TPA Name and Number must be provided when submitting Integrated Oncology requisition.